Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, speaks with Meg Rivers, managing editor, about: 1) her journey into the world of pharma, including her transition from being a physician/surgeon to working in clinical trials; 2) both women’s and men’s reproductive health; 3) the latest technologies in fertility treatment (for men and women); 4) unmet needs in fertility care; 5) trends in contraception and fertility treatment; 6) DE&I and access to care, and 7) predictions for the contraception and fertility treatment spaces in the coming years